IP Verse

Lederer & Keller patent opposition analysis

The comprehensive analysis of Lederer & Keller opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Lederer & Keller

Stay updated with the latest patent oppositions filed by Lederer & Keller

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3597659
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHDec 1, 2023LEDERER & KELLER
EP3672906
Autothermal Ammonia Cracking ProcessHALDOR TOPSENov 14, 2023LEDERER & KELLER
EP3463345
Pharmaceutical CombinationsCAPONIGROAug 1, 2023LEDERER & KELLER
EP3574914
Corticosteroid CompositionsVIROPHARMA BIOLOGICSSep 1, 2022DR FALK PHARMA
EP3464373
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL MYERS SQUIBBJul 26, 2022LEDERER & KELLER
EP3437645
Film-Coated Tablet Having High Chemical Stability Of Active IngredientINTERCEPT PHARMACEUTICALSJun 21, 2022SANDOZ
EP2585075
Methods Of Treatment For Esophageal InflammationMERITAGE PHARMAMay 4, 2022DR FALK PHARMA
EP3435985
Granulate Formulation Of 5-Methy!-1-Pheny!-2(1H)-Pyridone And Method Of Making The SameF HOFFMANN LA ROCHEFeb 8, 2022LEDERER & KELLER
EP3526229
Process For Preparing Glucopyranosyl-Substituted Benzyl-Benzene DerivativesBOEHRINGER INGELHEIMJan 26, 2022LEDERER & KELLER
EP3656765
Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolGRNENTHALJan 13, 2022LEDERER & KELLER

Top clients of Lederer & Keller

Top companies who are the clients of Lederer & Keller

CompanyTotal
LEDERER & KELLER30
TEVA PHARMACEUTICALS10
DR FALK PHARMA8
SANDOZ4
HEXAL4
DSM NUTRITIONAL PRODUCTS3
LUMMUS NOVOLEN TECHNOLOGY3
LUYE PHARMA SWITZERLAND1
PENTAFARMA SOCIEDADE TECNICO MEDICINAL1
STADA ARZNEIMITTEL1